|
S.V. Shalaev (1, 2), Z.M. Safiullina (1), N.A. Mikhalchuk (1)
STATINS AND THE RISK FOR NEW-ONSET DIABETES: RISK-BENEFIT RATIO. MODERN VIWES ON TARGET LIPID LEVELS IN DIABETES PATIENTS
|
14-18 |
|
E.V. Biryukova
FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE - NEW STEP IN THE IMPROVEMENT OF TREATMENT COMPLIANCE IN TYPE 2 DIABETES MELLITUS
|
19-25 |
|
M.B. Antsiferov (1), V.S. Pronin (2)
OPTIMIZATION OF TREATMENT OF PATIENTS WITH ACROMEGALY: INCREASE THE INTERVAL BETWEEN INJECTIONS OF LANREOTIDE
|
26-29 |
|
M.B. Antsiferov
NEW APPROACHES TO THE THERAPY OF CUSHING’S DISEASE
|
30-36 |
|
A.S. Ametov, M.V. Stelmakh
COMPREHENSIVE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH OBESITY
|
37-42 |
|
O.V. Zanozina, Yu.A. Sorokina, L.V. Lovtsova, N.N. Borovkov
ANALYSIS OF THE EFFICACY AND SAFETY OF DOMESTIC INSULIN NPH RINSULIN IN NIZHNY NOVGOROD
|
43-47 |
|
V.N. Khramilin, V.L. Andreeva, I.Yu. Demidova
COMBINATION THERAPY OF PAINFUL DIABETIC POLYNEUROPATHY: RESULTS OF PILOT STUDY
|
48-53 |
|
A.F. Verbovoy, L.A. Sharonova, R.I. Akhmerova
EFFECTS OF SHORT-TERM THERAPY WITH ROSUVASTATIN ON LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE
|
54-57 |
|
F.N. Chavdar, Yu. V. Kovaleva, A.P. Maslov, M.N. Baranova, N.V. Ryzhkova, L.N. Bazhenova, Z.V. Getman
EFFECTS OF SHORT-TERM THERAPY WITH ROSUVASTATIN ON LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE
|
58-61 |
|
I.V. Glinkina
ORIGIN STUDY (OUTCOME REDUCTION WITH INITIAL GLARGINE INTERVENTION) 2 YEARS LATER: WHAT’S NEW?
|
62-70 |
|
E.V.Surkova
EFFICACY AND SAFETY OF BIPHASIC INSULIN ANALOGUE NOVOMIX -30 IN TYPE 2 DIABETES MELLITUS: FROM CLINICAL RESEARCH TO REAL PRACTICE
|
72-78 |
|
N.V. Zaitseva, M.Sh. Shamkhalova
COMBINATION THERAPY WITH GLIMEPIRIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. THE RESULTS OF OBSERVATIONAL STUDIES
|
80-84 |
|
N.A. Mazerkina
DRUG VAZOMIRIN IN THE THERAPY OF CENTRAL DIABETES INSIPIDUS IN CHILDREN
|
86-90 |
|
D.V. Nebieridze, A.F. Sarycheva, T.V. Kamyshova
CURRENT ISSUES OF CONTROL OF ARTERIAL HYPERTENSION AND LIPID DISORDERS: FOCUS ON ADHERENCE TO THE TREATMENT
|
91-95 |
Русский
